Miller, PhD, opens the CMSC & ACTRIMS
Cooperative Meeting with a lecture entitled: “Tolerance Directed Immunotherapies Employing Biodegradable PLG Nanoparticles - The Future of MS Treatment,” on Wednesday, May 28th.
C A Press Briefing will be held in the press briefing room with an interactive session with the ACTRIMS
and ECTRIMS Steering Committee Members along with a few Young Investigators who are conducting exciting research work.
On the other side of the Atlantic, ACTRIMS
focused on the search for biomarkers, or easy-to-read signs to diagnose MS or track the impact of treatment.
th] triennial joint meeting of ACTRIMS
and ECTRIMS where researchers from all over the world will gather to present on every aspect of MS research from new therapeutic data in pivotal trials, to underlying disease pathology and genetic factors impacting MS, to remyelination and repair.
During the meeting, there will also be Burning Debates and Q&A discussions streaming live on ACTRIMS
and ECTRIMS social media channels.
On October 12, 2011, Biogen Idec announced a robust selection of data from the company's multiple sclerosis (MS) franchise were presented in 48 posters and five platform presentations during ECTRIMS and ACTRIMS
in Amsterdam, the Netherlands, October 19 through the 22.
Basic and clinical MS researchers collaborate in ECTRIMS and ACTRIMS
(European--or American--Committee for Treatment and Research in Multiple Sclerosis).
One-Year Phase II Data Presented at the 2010 ACTRIMS
Additional Preclinical Data to be Presented at the Fifth Joint Triennial Congress of ECTRIMS and ACTRIMS
Further Elucidate the Anti-inflammatory Mechanism of COPAXONE[R]
The substantial amount of data presented at this year's ECTRIMS and ACTRIMS
demonstrates our unwavering commitment to those living with MS and novel scientific approaches to understanding and treating the disease," said Douglas E.
interferon beta-1a) data will be presented at the 2014 Cooperative Meeting of CMSC (Consortium of Multiple Sclerosis Centers) and ACTRIMS
(Americas Committee on Research & Treatment in Multiple Sclerosis), taking place from May 28 - 31, in Dallas, TX.
attends scientific meetings and provides coverage of key issues at ACTRIMS
, ECTRIMS, and AAN.